CTS (CTS) Financials

$42.11 -0.57 (-1.34%)

Closing price 05/20/2025 03:59 PM Eastern

Extended Trading

$42.16 +0.05 (+0.11%)

As of 08:00 AM Eastern

Annual Income Statements for CTS

This table shows CTS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	58	61	60	-42	35	36	47	14	34	6.95	27
Consolidated Net Income / (Loss)	58	61	60	-42	35	36	47	14	34	6.95	27
Net Income / (Loss) Continuing Operations	58	61	60	-42	35	36	47	14	34	6.95	27
Total Pre-Tax Income	71	75	81	-61	45	50	58	40	57	12	39
Total Operating Income	73	75	93	76	45	54	61	38	63	18	42
Total Gross Profit	189	191	211	185	139	158	165	140	140	127	130
Total Revenue	516	550	587	513	424	469	470	423	397	382	404
Operating Revenue	516	550	587	513	424	469	470	423	397	382	404
Total Cost of Revenue	327	360	376	328	285	311	306	283	256	255	274
Operating Cost of Revenue	327	360	376	328	285	311	306	283	256	255	274
Total Operating Expenses	116	116	118	108	94	104	104	102	77	109	88
Selling, General & Admin Expense	88	84	92	83	68	70	74	72	62	60	61
Research & Development Expense	23	25	24	24	24	26	25	25	24	22	23
Restructuring Charge	4.70	7.07	1.91	1.69	1.83	7.45	5.06	4.14	3.05	15	5.94
Total Other Income / (Expense), net	-1.56	0.10	-12	-137	0.35	-3.55	-2.94	1.76	-5.92	-5.85	-2.98
Interest Expense	4.24	3.33	2.19	2.11	3.27	2.65	2.09	3.34	3.70	2.63	2.33
Interest & Investment Income	4.28	4.63	1.33	0.84	1.05	1.74	1.83	1.28	1.31	3.07	2.79
Other Income / (Expense), net	-1.60	-1.19	-11	-136	2.58	-2.64	-2.68	3.82	-3.52	-6.30	-3.44
Income Tax Expense	13	15	21	-19	11	14	12	26	23	5.31	13
Basic Earnings per Share	$1.91	$1.93	$1.86	($1.30)	$1.07	$1.11	$1.41	$0.44	$1.05	$0.21	$0.79
Weighted Average Basic Shares Outstanding	30.41M	31.36M	31.97M	32.33M	32.32M	32.70M	33.02M	32.89M	32.73M	32.96M	33.62M
Diluted Earnings per Share	$1.89	$1.92	$1.85	($1.30)	$1.06	$1.09	$1.39	$0.43	$1.03	$0.21	$0.78
Weighted Average Diluted Shares Outstanding	30.72M	31.58M	32.24M	32.33M	32.58M	33.11M	33.57M	33.42M	33.25M	33.48M	34.13M
Weighted Average Basic & Diluted Shares Outstanding	30.04M	30.79M	31.67M	32.15M	32.35M	64.87M	33M	32.80M	32.70M	33.10M	33.60M
Cash Dividends to Common per Share	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16	$0.16

This table shows CTS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	13	14	19	15	11	15	14	13	18	15	12
Consolidated Net Income / (Loss)	13	14	19	15	11	15	14	13	18	15	12
Net Income / (Loss) Continuing Operations	13	14	19	15	11	15	14	13	18	15	12
Total Pre-Tax Income	16	17	22	18	14	18	19	16	23	21	17
Total Operating Income	16	19	21	18	15	16	18	18	22	22	23
Total Gross Profit	47	48	50	46	45	42	46	51	52	51	53
Total Revenue	126	127	132	130	126	125	135	145	146	142	152
Operating Revenue	126	127	132	130	126	125	135	145	146	142	152
Total Cost of Revenue	79	80	83	84	81	83	88	94	94	91	99
Operating Cost of Revenue	79	80	83	84	81	83	88	94	94	91	99
Total Operating Expenses	30	29	28	29	31	26	28	32	29	29	31
Selling, General & Admin Expense	24	22	23	21	22	19	19	24	22	23	24
Research & Development Expense	6.19	5.67	5.03	6.09	6.60	5.29	6.32	6.72	6.59	5.41	6.21
Restructuring Charge	0.45	1.04	0.77	1.19	1.69	1.04	3.23	1.90	0.91	0.48	0.49
Total Other Income / (Expense), net	-0.16	-1.66	0.97	0.01	-0.88	1.37	0.55	-2.35	0.53	-0.86	-5.35
Interest Expense	1.17	1.30	1.31	0.83	0.80	0.82	1.00	0.82	0.69	0.70	0.34
Interest & Investment Income	0.45	0.48	0.97	1.44	1.39	1.54	0.95	1.07	1.06	0.72	0.17
Other Income / (Expense), net	0.56	-0.84	1.31	-0.60	-1.46	0.66	0.59	-2.61	0.17	-0.87	-5.17
Income Tax Expense	2.76	3.74	3.76	3.06	2.54	2.31	4.77	3.18	4.37	5.83	5.50
Basic Earnings per Share	$0.45	$0.45	$0.62	$0.48	$0.36	$0.49	$0.45	$0.41	$0.58	$0.47	$0.37
Weighted Average Basic Shares Outstanding	30.01M	30.41M	30.30M	30.51M	30.74M	31.36M	31.30M	31.49M	31.63M	31.97M	31.87M
Diluted Earnings per Share	$0.44	$0.44	$0.61	$0.48	$0.36	$0.49	$0.44	$0.41	$0.58	$0.46	$0.37
Weighted Average Diluted Shares Outstanding	30.33M	30.72M	30.54M	30.73M	30.99M	31.58M	31.51M	31.69M	31.89M	32.24M	32.09M
Weighted Average Basic & Diluted Shares Outstanding	29.84M	30.04M	30.12M	30.37M	30.57M	30.79M	31.16M	31.36M	31.54M	31.67M	31.88M
Cash Dividends to Common per Share	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04	$0.04

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-70	6.97	15	50	-8.47	-0.69	-13	-0.23	-43	22	10
Net Cash From Operating Activities	99	89	121	86	77	64	58	58	47	39	33
Net Cash From Continuing Operating Activities	99	89	121	86	77	64	58	58	47	39	33
Net Income / (Loss) Continuing Operations	58	61	60	-42	35	36	47	14	34	6.95	27
Consolidated Net Income / (Loss)	58	61	60	-42	35	36	47	14	34	6.95	27
Depreciation Expense	31	29	30	27	27	25	23	21	19	16	17
Non-Cash Adjustments To Reconcile Net Income	12	3.23	11	140	8.77	8.11	5.60	17	-8.75	24	6.69
Changes in Operating Assets and Liabilities, net	-1.36	-3.66	21	-39	6.65	-4.47	-16	6.37	4.18	-5.47	-15
Net Cash From Investing Activities	-141	-18	-111	-16	-23	-96	-28	-37	-81	-9.13	-8.00
Net Cash From Continuing Investing Activities	-141	-18	-111	-16	-23	-96	-28	-37	-81	-9.13	-8.00
Purchase of Property, Plant & Equipment	-19	-15	-14	-16	-15	-22	-28	-18	-21	-9.72	-13
Acquisitions	-122	-3.36	-97	-0.26	-8.31	-74	0.00	-19	-73	-1.29	0.00
Net Cash From Financing Activities	-28	-65	4.34	-21	-61	30	-42	-21	-8.64	-7.83	-16
Net Cash From Continuing Financing Activities	-28	-65	4.34	-21	-61	30	-42	-21	-8.64	-7.83	-16
Repayment of Debt	-892	-775	-723	-809	-3,793	-1,886	-1,060	-1,519	-2,458	-1,344	-1,034
Repurchase of Common Equity	-43	-41	-21	-8.79	-8.08	-12	-9.44	0.00	0.00	-18	-8.00
Payment of Dividends	-4.89	-5.04	-5.13	-5.17	-5.18	-5.24	-5.29	-5.26	-5.23	-5.29	-5.37
Issuance of Debt	916	758	757	804	3,747	1,936	1,034	1,505	2,457	1,359	1,031
Other Financing Activities, net	-4.21	-3.26	-2.72	-2.15	-2.97	-2.66	-1.47	-1.60	-1.81	-0.15	0.58
Effect of Exchange Rate Changes	-0.34	1.65	1.10	0.16	-0.75	0.35	0.19	-0.79	-0.42	0.23	0.72
Cash Interest Paid	4.23	3.13	2.02	1.95	2.60	1.96	1.58	2.13	2.94	2.42	2.11
Cash Income Taxes Paid	17	20	20	17	12	11	9.92	11	10	6.78	7.99

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-4.05	-0.54	-66	-1.18	-1.45	3.76	9.23	7.34	-13	9.00	49
Net Cash From Operating Activities	16	26	35	20	18	32	22	23	11	25	60
Net Cash From Continuing Operating Activities	16	26	35	20	18	32	22	23	11	25	60
Net Income / (Loss) Continuing Operations	13	14	19	15	11	15	14	13	18	15	12
Consolidated Net Income / (Loss)	13	14	19	15	11	15	14	13	18	15	12
Depreciation Expense	8.49	8.28	7.99	7.33	7.33	7.29	7.25	7.26	6.92	8.03	7.96
Non-Cash Adjustments To Reconcile Net Income	2.31	4.45	4.74	0.29	2.14	1.68	-3.37	2.28	2.64	2.54	2.13
Changes in Operating Assets and Liabilities, net	-8.65	-0.38	3.99	-2.70	-2.27	7.78	4.28	0.99	-17	-0.04	38
Net Cash From Investing Activities	-4.47	-6.10	-126	-4.64	-4.04	-3.50	-2.75	-3.95	-7.90	-5.40	-2.27
Net Cash From Continuing Investing Activities	-4.47	-6.10	-126	-4.64	-4.04	-3.50	-2.75	-3.95	-7.90	-5.40	-2.27
Purchase of Property, Plant & Equipment	-4.47	-6.10	-3.87	-4.64	-4.04	-3.50	-2.75	-3.95	-4.54	-5.07	-2.27
Acquisitions	0.00	-	-122	-	0.00	-	-	-0.00	-3.36	-0.33	-
Net Cash From Financing Activities	-16	-20	25	-16	-16	-25	-9.97	-13	-17	-11	-8.77
Net Cash From Continuing Financing Activities	-16	-20	25	-16	-16	-25	-9.97	-13	-17	-11	-8.77
Repayment of Debt	-264	-291	-266	-168	-168	-181	-344	-46	-204	-205	-218
Repurchase of Common Equity	-6.47	-7.81	-12	-11	-12	-15	-8.33	-8.76	-8.80	-8.00	-1.78
Payment of Dividends	-1.20	-1.21	-1.22	-1.23	-1.23	-1.25	-1.26	-1.26	-1.27	-1.28	-1.28
Issuance of Debt	259	280	303	165	168	172	343	42	201	203	212
Other Financing Activities, net	-2.63	0.02	-0.02	-1.09	-3.12	-0.01	-0.01	-0.10	-3.14	-0.17	-0.16
Effect of Exchange Rate Changes	0.80	0.05	-0.55	-0.42	0.58	0.66	-0.18	1.21	-0.04	0.23	-0.18
Cash Interest Paid	1.06	1.45	1.22	0.82	0.74	0.78	0.63	0.79	0.93	0.50	0.55
Cash Income Taxes Paid	2.91	4.46	4.08	4.27	3.80	5.11	5.40	5.53	4.20	7.47	5.00

This table presents CTS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	766	741	748	664	626	643	548	540	518	483	457
Total Current Assets	244	319	326	289	233	237	239	234	216	246	240
Cash & Equivalents	94	164	157	141	92	100	101	114	114	157	135
Accounts Receivable	78	79	91	82	81	78	80	71	63	55	57
Inventories, net	54	60	62	50	46	42	43	37	29	25	28
Other Current Assets	19	17	16	16	15	17	15	13	11	9.86	21
Plant, Property, & Equipment, net	94	93	97	97	97	105	99	88	82	70	71
Total Noncurrent Assets	427	329	325	278	295	301	210	218	220	168	145
Goodwill	200	158	152	110	109	106	71	71	62	34	32
Intangible Assets	164	104	108	70	79	85	60	67	64	35	37
Noncurrent Deferred & Refundable Income Taxes	28	25	23	25	24	20	22	21	46	64	43
Employee Benefit Assets	0.00	0.00	0.00	49	57	62	54	57	46	34	32
Other Noncurrent Operating Assets	36	42	42	24	26	28	2.04	2.10	1.74	1.34	1.25
Total Liabilities & Shareholders' Equity	766	741	748	664	626	643	548	540	518	483	457
Total Liabilities	235	214	242	201	202	238	170	196	200	202	167
Total Current Liabilities	98	97	113	114	105	97	104	102	98	95	80
Accounts Payable	43	43	53	56	50	48	52	49	40	40	43
Accrued Expenses	34	35	35	37	38	36	37	41	46	47	25
Current Employee Benefit Liabilities	16	15	20	18	13	9.56	15	12	11	7.15	11
Other Current Liabilities	4.72	4.39	3.94	3.39	3.29	2.79	0.00	-	-	-	-
Total Noncurrent Liabilities	138	117	130	87	97	141	66	93	102	107	87
Long-Term Debt	91	68	84	50	55	100	50	76	89	91	75
Noncurrent Deferred & Payable Income Tax Liabilities	13	15	16	5.89	7.01	5.64	3.99	3.80	2.37	-	-
Noncurrent Employee Benefit Liabilities	3.93	4.66	5.05	6.89	7.47	6.63	-	-	-	-	-
Other Noncurrent Operating Liabilities	30	30	25	24	28	29	5.92	6.18	3.21	9.17	9.11
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Equity & Noncontrolling Interests	531	527	506	464	424	405	378	344	318	282	290
Total Preferred & Common Equity	531	527	506	464	424	405	378	344	318	282	290
Total Common Equity	531	527	506	464	424	405	378	344	318	282	290
Common Stock	367	364	363	357	353	352	350	346	343	342	339
Retained Earnings	655	602	547	492	539	510	479	420	411	382	380
Treasury Stock	-487	-444	-403	-381	-373	-364	-353	-343	-343	-343	-325
Accumulated Other Comprehensive Income / (Loss)	-4.27	4.26	-0.67	-4.53	-96	-92	-98	-79	-93	-99	-104

This table presents CTS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	766	789	726	733	754	756	747	735
Total Current Assets	244	256	315	318	334	330	323	326
Cash & Equivalents	90	95	161	162	160	151	144	148
Accounts Receivable	81	86	85	81	90	98	98	97
Inventories, net	54	57	52	58	65	63	63	63
Other Current Assets	18	17	17	17	19	19	18	18
Plant, Property, & Equipment, net	94	93	92	92	93	95	96	96
Total Noncurrent Assets	428	440	319	323	327	331	328	312
Goodwill	203	195	156	156	154	156	156	139
Intangible Assets	162	181	97	100	104	109	110	106
Noncurrent Deferred & Refundable Income Taxes	28	27	27	26	24	23	23	23
Other Noncurrent Operating Assets	35	38	39	41	45	44	39	44
Total Liabilities & Shareholders' Equity	766	789	726	733	754	756	747	735
Total Liabilities	227	259	203	212	231	235	233	244
Total Current Liabilities	92	104	92	96	103	107	106	122
Accounts Payable	43	45	41	46	50	53	53	66
Accrued Expenses	32	37	32	33	36	35	37	36
Current Employee Benefit Liabilities	13	17	15	13	13	14	12	17
Other Current Liabilities	4.34	4.59	4.37	4.40	4.44	4.29	4.03	3.53
Total Noncurrent Liabilities	135	155	110	116	128	127	127	122
Long-Term Debt	87	103	65	68	77	77	80	85
Noncurrent Deferred & Payable Income Tax Liabilities	13	14	14	14	15	16	16	5.52
Noncurrent Employee Benefit Liabilities	3.91	4.56	4.58	4.62	4.96	5.02	5.02	6.25
Other Noncurrent Operating Liabilities	31	34	27	29	31	29	26	25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	538	531	523	521	523	521	514	491
Total Preferred & Common Equity	538	531	523	521	523	521	514	491
Total Common Equity	538	531	523	521	523	521	514	491
Common Stock	365	365	363	362	364	363	361	361
Retained Earnings	665	643	626	612	588	575	564	533
Treasury Stock	-493	-479	-467	-456	-429	-420	-412	-395
Accumulated Other Comprehensive Income / (Loss)	1.27	2.02	0.78	2.94	-0.68	3.69	0.70	-8.85

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.30%	-6.21%	14.42%	20.95%	-9.58%	-0.32%	11.23%	6.63%	3.76%	-5.37%	-1.33%
EBITDA Growth	-0.46%	-7.89%	440.76%	-143.94%	-1.88%	-6.28%	28.40%	-18.24%	200.69%	-52.18%	9.92%
EBIT Growth	-3.63%	-9.49%	236.90%	-224.96%	-6.79%	-12.31%	37.93%	-29.06%	404.76%	-69.62%	100.19%
NOPAT Growth	-1.76%	-11.92%	28.19%	55.54%	-11.06%	-20.83%	253.79%	-63.58%	269.28%	-63.99%	1,358.87%
Net Income Growth	-3.99%	1.61%	242.30%	-220.70%	-4.04%	-22.32%	222.07%	-57.98%	394.39%	-73.78%	775.03%
EPS Growth	-1.56%	3.78%	242.31%	-222.64%	-2.75%	-21.58%	223.26%	-58.25%	390.48%	-73.08%	750.00%
Operating Cash Flow Growth	11.80%	-26.72%	40.70%	12.19%	19.22%	10.75%	0.18%	22.98%	20.56%	17.40%	-11.24%
Free Cash Flow Firm Growth	-160.23%	712.00%	-88.58%	29.18%	234.90%	-237.17%	1,837.25%	103.59%	-262.45%	-44.90%	-31.19%
Invested Capital Growth	22.61%	-0.59%	16.36%	-3.72%	-4.49%	23.76%	6.68%	4.20%	36.56%	-6.45%	-6.90%
Revenue Q/Q Growth	0.53%	-3.10%	1.69%	1.89%	1.92%	-1.06%	1.99%	2.25%	2.14%	-1.82%	-0.49%
EBITDA Q/Q Growth	2.25%	-4.28%	6.66%	-17.38%	9.89%	-3.91%	25.71%	-14.36%	18.35%	-31.26%	-10.59%
EBIT Q/Q Growth	1.79%	-4.95%	7.40%	-8.53%	15.55%	-6.40%	37.73%	-20.92%	27.40%	-43.82%	5.78%
NOPAT Q/Q Growth	1.34%	-2.16%	6.12%	1.73%	11.42%	-17.62%	199.51%	-62.87%	176.40%	-62.63%	-22.95%
Net Income Q/Q Growth	-2.87%	0.63%	10.73%	-16.03%	16.40%	-17.19%	203.20%	-60.28%	176.88%	-70.57%	29.24%
EPS Q/Q Growth	-2.58%	1.59%	11.45%	-16.07%	15.22%	-17.42%	215.91%	-67.42%	45.07%	-16.00%	59.18%
Operating Cash Flow Q/Q Growth	-5.80%	8.04%	-0.46%	-1.67%	5.23%	14.34%	8.41%	-3.42%	-3.86%	-7.06%	21.63%
Free Cash Flow Firm Q/Q Growth	7.04%	24.12%	-49.41%	9.03%	7.19%	-4.60%	328.84%	-88.06%	-5.31%	-52.66%	-41.22%
Invested Capital Q/Q Growth	-2.02%	-2.00%	1.12%	-1.78%	-0.52%	-0.50%	1.41%	-1.99%	2.21%	-8.47%	-11.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.67%	34.68%	35.87%	35.99%	32.79%	33.60%	35.06%	33.20%	35.40%	33.25%	32.17%
EBITDA Margin	19.80%	18.63%	18.97%	-6.37%	17.54%	16.16%	17.19%	14.89%	19.42%	6.70%	13.26%
Operating Margin	14.11%	13.64%	15.85%	14.91%	10.64%	11.47%	12.97%	9.10%	15.92%	4.74%	10.48%
EBIT Margin	13.80%	13.42%	13.90%	-11.62%	11.25%	10.91%	12.40%	10.00%	15.04%	3.09%	9.63%
Profit (Net Income) Margin	11.27%	11.00%	10.15%	-8.16%	8.18%	7.71%	9.89%	3.42%	8.67%	1.82%	6.56%
Tax Burden Percent	81.59%	80.55%	73.79%	68.77%	76.27%	71.91%	80.09%	35.89%	60.06%	56.72%	67.40%
Interest Burden Percent	100.06%	101.75%	98.94%	102.13%	95.34%	98.22%	99.56%	95.13%	95.98%	103.77%	101.18%
Effective Tax Rate	18.41%	19.46%	26.21%	0.00%	23.73%	28.09%	19.91%	64.11%	39.94%	43.28%	32.60%
Return on Invested Capital (ROIC)	12.39%	14.00%	17.05%	14.11%	8.70%	10.58%	15.43%	4.60%	14.89%	4.61%	11.95%
ROIC Less NNEP Spread (ROIC-NNEP)	14.95%	13.91%	28.04%	162.44%	7.29%	20.49%	20.76%	2.53%	22.80%	9.89%	15.63%
Return on Net Nonoperating Assets (RNNOA)	-1.41%	-2.28%	-4.76%	-23.55%	-0.33%	-1.35%	-2.54%	-0.23%	-3.42%	-2.18%	-2.90%
Return on Equity (ROE)	10.99%	11.72%	12.29%	-9.44%	8.37%	9.23%	12.89%	4.37%	11.47%	2.43%	9.04%
Cash Return on Invested Capital (CROIC)	-7.92%	14.59%	1.93%	17.91%	13.29%	-10.66%	8.97%	0.49%	-16.02%	11.28%	19.10%
Operating Return on Assets (OROA)	9.44%	9.92%	11.55%	-9.24%	7.52%	8.59%	10.73%	8.00%	11.92%	2.51%	8.30%
Return on Assets (ROA)	7.71%	8.13%	8.43%	-6.49%	5.46%	6.07%	8.55%	2.73%	6.87%	1.48%	5.66%
Return on Common Equity (ROCE)	10.99%	11.72%	12.29%	-9.44%	8.37%	9.23%	12.89%	4.37%	11.47%	2.43%	9.04%
Return on Equity Simple (ROE_SIMPLE)	10.95%	11.49%	11.77%	-9.03%	8.19%	8.92%	12.31%	4.20%	10.82%	2.47%	9.15%
Net Operating Profit after Tax (NOPAT)	59	60	69	54	34	39	49	14	38	10	29
NOPAT Margin	11.51%	10.98%	11.69%	10.44%	8.12%	8.25%	10.39%	3.27%	9.56%	2.69%	7.06%
Net Nonoperating Expense Percent (NNEP)	-2.55%	0.10%	-10.99%	-148.33%	1.42%	-9.92%	-5.33%	2.07%	-7.91%	-5.28%	-3.68%
Return On Investment Capital (ROIC_SIMPLE)	9.55%	10.17%	11.63%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	63.33%	65.33%	64.13%	64.01%	67.21%	66.40%	64.94%	66.80%	64.60%	66.75%	67.83%
SG&A Expenses to Revenue	17.12%	15.23%	15.59%	16.10%	15.99%	15.01%	15.64%	17.01%	15.54%	15.59%	15.11%
R&D to Revenue	4.53%	4.53%	4.11%	4.65%	5.73%	5.54%	5.38%	5.94%	6.06%	5.88%	5.58%
Operating Expenses to Revenue	22.56%	21.04%	20.03%	21.08%	22.15%	22.12%	22.09%	24.10%	19.48%	28.51%	21.69%
Earnings before Interest and Taxes (EBIT)	71	74	82	-60	48	51	58	42	60	12	39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	102	103	111	-33	74	76	81	63	77	26	54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.99	2.58	2.47	2.53	2.58	2.36	2.21	2.39	2.22	1.95	1.95
Price to Tangible Book Value (P/TBV)	9.50	5.12	5.08	4.13	4.65	4.48	3.38	3.99	3.68	2.58	2.55
Price to Revenue (P/Rev)	3.08	2.47	2.13	2.28	2.58	2.04	1.77	1.94	1.78	1.44	1.40
Price to Earnings (P/E)	27.33	22.44	20.95	0.00	31.49	26.50	17.93	56.87	20.54	78.97	21.28
Dividend Yield	0.30%	0.37%	0.41%	0.44%	0.59%	0.54%	0.63%	0.64%	0.74%	0.95%	0.95%
Earnings Yield	3.66%	4.46%	4.77%	0.00%	3.18%	3.77%	5.58%	1.76%	4.87%	1.27%	4.70%
Enterprise Value to Invested Capital (EV/IC)	3.00	2.93	2.71	2.90	2.73	2.37	2.40	2.56	2.32	2.24	2.19
Enterprise Value to Revenue (EV/Rev)	3.07	2.29	2.00	2.11	2.49	2.04	1.67	1.85	1.72	1.26	1.25
Enterprise Value to EBITDA (EV/EBITDA)	15.52	12.30	10.55	0.00	14.18	12.63	9.69	12.45	8.86	18.85	9.42
Enterprise Value to EBIT (EV/EBIT)	22.27	17.09	14.40	0.00	22.11	18.71	13.42	18.54	11.44	40.87	12.98
Enterprise Value to NOPAT (EV/NOPAT)	26.69	20.88	17.12	20.18	30.65	24.74	16.03	56.77	17.99	47.01	17.70
Enterprise Value to Operating Cash Flow (EV/OCF)	15.96	14.21	9.69	12.54	13.74	14.87	13.47	13.51	14.46	12.34	15.14
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	20.04	151.43	15.91	20.06	0.00	27.57	534.72	0.00	19.22	11.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.17	0.13	0.17	0.11	0.13	0.25	0.13	0.22	0.28	0.32	0.26
Long-Term Debt to Equity	0.17	0.13	0.17	0.11	0.13	0.25	0.13	0.22	0.28	0.32	0.26
Financial Leverage	-0.09	-0.16	-0.17	-0.15	-0.05	-0.07	-0.12	-0.09	-0.15	-0.22	-0.19
Leverage Ratio	1.43	1.44	1.46	1.45	1.53	1.52	1.51	1.60	1.67	1.65	1.60
Compound Leverage Factor	1.43	1.47	1.44	1.49	1.46	1.49	1.50	1.52	1.60	1.71	1.62
Debt to Total Capital	14.67%	11.36%	14.18%	9.74%	11.42%	19.75%	11.68%	18.16%	22.09%	24.36%	20.56%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.25%	0.00%	0.00%
Long-Term Debt to Total Capital	14.67%	11.36%	14.18%	9.74%	11.42%	19.75%	11.68%	18.16%	21.84%	24.36%	20.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	85.33%	88.64%	85.82%	90.26%	88.58%	80.25%	88.32%	81.84%	77.91%	75.64%	79.44%
Debt to EBITDA	0.89	0.66	0.75	-1.53	0.73	1.32	0.62	1.21	1.17	3.54	1.40
Net Debt to EBITDA	-0.03	-0.94	-0.66	2.80	-0.50	-0.01	-0.63	-0.59	-0.31	-2.59	-1.11
Long-Term Debt to EBITDA	0.89	0.66	0.75	-1.53	0.73	1.32	0.62	1.21	1.16	3.54	1.40
Debt to NOPAT	1.54	1.12	1.22	0.93	1.59	2.58	1.02	5.52	2.38	8.83	2.63
Net Debt to NOPAT	-0.05	-1.59	-1.07	-1.71	-1.08	-0.01	-1.04	-2.70	-0.62	-6.45	-2.09
Long-Term Debt to NOPAT	1.54	1.12	1.22	0.93	1.59	2.58	1.02	5.52	2.35	8.83	2.63
Altman Z-Score	6.46	6.37	5.60	5.33	5.62	4.78	5.67	4.94	4.65	3.99	4.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.50	3.29	2.89	2.53	2.22	2.45	2.30	2.28	2.20	2.60	3.01
Quick Ratio	1.76	2.50	2.20	1.96	1.65	1.84	1.74	1.80	1.80	2.24	2.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	63	7.76	68	53	-39	28	1.47	-41	25	46
Operating Cash Flow to CapEx	532.55%	602.60%	845.58%	550.74%	516.78%	298.23%	204.15%	330.70%	575.35%	499.06%	416.97%
Free Cash Flow to Firm to Interest Expense	-8.96	18.91	3.54	32.18	16.07	-14.72	13.63	0.44	-11.03	9.56	19.61
Operating Cash Flow to Interest Expense	23.44	26.66	55.29	40.81	23.47	24.32	27.89	17.36	12.75	14.90	14.34
Operating Cash Flow Less CapEx to Interest Expense	19.04	22.24	48.75	33.40	18.93	16.17	14.23	12.11	10.53	11.91	10.90
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.68	0.74	0.83	0.79	0.67	0.79	0.86	0.80	0.79	0.81	0.86
Accounts Receivable Turnover	6.60	6.49	6.78	6.29	5.33	5.95	6.27	6.35	6.77	6.86	6.76
Inventory Turnover	5.75	5.88	6.73	6.88	6.47	7.27	7.63	8.66	9.62	9.72	9.12
Fixed Asset Turnover	5.52	5.80	6.04	5.28	4.19	4.59	5.01	4.97	5.22	5.41	5.52
Accounts Payable Turnover	7.58	7.44	6.92	6.19	5.77	6.22	6.04	6.33	6.38	6.10	6.06
Days Sales Outstanding (DSO)	55.28	56.20	53.84	58.06	68.42	61.30	58.22	57.47	53.91	53.21	54.01
Days Inventory Outstanding (DIO)	63.48	62.07	54.20	53.02	56.42	50.24	47.84	42.14	37.93	37.53	40.03
Days Payable Outstanding (DPO)	48.12	49.09	52.74	58.94	63.21	58.72	60.44	57.64	57.22	59.81	60.20
Cash Conversion Cycle (CCC)	70.63	69.19	55.30	52.14	61.63	52.82	45.62	41.97	34.61	30.93	33.84
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	528	430	433	372	387	405	327	307	294	215	230
Invested Capital Turnover	1.08	1.28	1.46	1.35	1.07	1.28	1.49	1.41	1.56	1.72	1.69
Increase / (Decrease) in Invested Capital	97	-2.54	61	-14	-18	78	20	12	79	-15	-17
Enterprise Value (EV)	1,585	1,262	1,175	1,081	1,055	957	783	784	682	483	505
Market Capitalization	1,588	1,358	1,248	1,172	1,092	958	834	822	706	549	564
Book Value per Share	$17.63	$16.91	$15.88	$14.39	$13.13	$12.43	$11.42	$10.44	$9.70	$8.63	$8.66
Tangible Book Value per Share	$5.55	$8.51	$7.71	$8.81	$7.28	$6.56	$7.46	$6.25	$5.85	$6.53	$6.61
Total Capital	622	594	590	514	478	505	428	420	408	372	365
Total Debt	91	68	84	50	55	100	50	76	90	91	75
Total Long-Term Debt	91	68	84	50	55	100	50	76	89	91	75
Net Debt	-3.08	-96	-73	-91	-37	-0.54	-51	-37	-24	-66	-60
Capital Expenditures (CapEx)	19	15	14	16	15	22	28	18	8.20	7.85	8.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	52	58	56	34	37	40	34	18	4.78	-5.59	26
Debt-free Net Working Capital (DFNWC)	147	222	213	175	128	141	135	131	119	151	160
Net Working Capital (NWC)	147	222	213	175	128	141	135	131	118	151	160
Net Nonoperating Expense (NNE)	1.27	-0.08	9.05	95	-0.27	2.55	2.35	-0.63	3.56	3.32	2.01
Net Nonoperating Obligations (NNO)	-3.08	-96	-73	-91	-37	-0.54	-51	-37	-24	-66	-60
Total Depreciation and Amortization (D&A)	31	29	30	27	27	25	23	21	17	14	15
Debt-free, Cash-free Net Working Capital to Revenue	10.16%	10.62%	9.60%	6.54%	8.61%	8.59%	7.32%	4.17%	1.20%	-1.46%	6.41%
Debt-free Net Working Capital to Revenue	28.45%	40.39%	36.33%	34.12%	30.25%	29.96%	28.77%	31.02%	29.89%	39.58%	39.71%
Net Working Capital to Revenue	28.45%	40.39%	36.33%	34.12%	30.25%	29.96%	28.77%	31.02%	29.64%	39.58%	39.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.91	$1.93	$1.86	($1.30)	$1.07	$1.11	$1.41	$0.44	$1.05	$0.21	$0.79
Adjusted Weighted Average Basic Shares Outstanding	30.41M	31.36M	31.97M	32.33M	32.32M	32.70M	33.02M	32.89M	32.73M	32.96M	33.62M
Adjusted Diluted Earnings per Share	$1.89	$1.92	$1.85	($1.30)	$1.06	$1.09	$1.39	$0.43	$1.03	$0.21	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	30.72M	31.58M	32.24M	32.33M	32.58M	33.11M	33.57M	33.42M	33.25M	33.48M	34.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	30.04M	30.79M	31.67M	32.15M	32.35M	64.87M	32.73M	32.94M	32.76M	32.58M	33.44M
Normalized Net Operating Profit after Tax (NOPAT)	63	66	70	55	36	44	53	30	33	26	31
Normalized NOPAT Margin	12.26%	12.02%	11.93%	10.67%	8.45%	9.38%	11.25%	7.17%	8.29%	6.69%	7.73%
Pre Tax Income Margin	13.81%	13.65%	13.76%	-11.87%	10.72%	10.72%	12.35%	9.52%	14.43%	3.21%	9.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	16.80	22.17	37.23	-28.24	14.58	19.33	27.99	12.66	16.11	4.50	16.72
NOPAT to Interest Expense	14.02	18.15	31.31	25.36	10.52	14.61	23.44	4.13	10.25	3.91	12.26
EBIT Less CapEx to Interest Expense	12.40	17.75	30.69	-35.65	10.04	11.17	14.33	7.41	13.89	1.51	13.28
NOPAT Less CapEx to Interest Expense	9.62	13.72	24.77	17.95	5.98	6.46	9.78	-1.12	8.03	0.92	8.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.41%	8.33%	8.61%	-12.36%	14.93%	14.49%	11.36%	36.41%	15.22%	76.09%	20.26%
Augmented Payout Ratio	81.70%	75.94%	44.61%	-33.34%	38.23%	46.99%	31.64%	36.41%	15.22%	336.20%	50.43%

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.02%	2.20%	-1.58%	-10.35%	-13.87%	-12.36%	-11.43%	0.14%	-1.15%	7.36%	24.13%
EBITDA Growth	24.21%	9.27%	18.22%	6.08%	-30.28%	-15.94%	2.35%	-4.92%	-10.96%	31.83%	130.71%
EBIT Growth	28.83%	7.40%	21.29%	8.44%	-41.48%	-18.53%	7.49%	-8.31%	-14.45%	37.15%	119.52%
NOPAT Growth	14.10%	5.49%	31.80%	-0.55%	-33.94%	-9.19%	-12.19%	-12.47%	-12.51%	35.83%	16.32%
Net Income Growth	20.22%	-11.19%	33.73%	14.03%	-39.39%	2.54%	18.42%	2.37%	-9.36%	63.01%	118.46%
EPS Growth	22.22%	-10.20%	38.64%	17.07%	-37.93%	6.52%	18.92%	5.13%	-7.94%	70.37%	118.78%
Operating Cash Flow Growth	-15.25%	-19.07%	59.91%	-16.19%	63.70%	25.97%	-63.34%	45.78%	-42.00%	-2.17%	183.08%
Free Cash Flow Firm Growth	-360.88%	-594.52%	-3,330.92%	-21.35%	225.78%	136.78%	107.45%	161.08%	-2,190.52%	-275.29%	-247.63%
Invested Capital Growth	25.40%	22.61%	22.63%	-4.70%	-5.43%	-0.59%	2.58%	-6.41%	11.58%	16.36%	13.02%
Revenue Q/Q Growth	-1.31%	-3.77%	1.74%	3.51%	0.85%	-7.33%	-7.32%	-0.56%	2.61%	-6.34%	4.78%
EBITDA Q/Q Growth	-4.18%	-14.08%	25.67%	20.05%	-15.70%	-7.05%	12.78%	-21.11%	1.65%	13.16%	4.77%
EBIT Q/Q Growth	-7.27%	-20.28%	32.75%	31.27%	-22.70%	-9.96%	18.68%	-29.16%	7.63%	18.79%	1.23%
NOPAT Q/Q Growth	-9.40%	-16.62%	21.57%	24.24%	-16.24%	4.18%	-8.26%	-17.47%	15.14%	0.74%	-8.56%
Net Income Q/Q Growth	-1.75%	-27.18%	27.03%	32.27%	-27.42%	9.66%	8.33%	-29.69%	22.78%	26.63%	-6.35%
EPS Q/Q Growth	0.00%	-27.87%	27.08%	33.33%	-26.53%	11.36%	7.32%	-29.31%	26.09%	24.32%	-5.13%
Operating Cash Flow Q/Q Growth	-40.21%	-26.67%	80.32%	7.20%	-42.90%	44.88%	-5.49%	109.38%	-56.06%	-57.84%	275.87%
Free Cash Flow Firm Q/Q Growth	-15.01%	-1.08%	-328.04%	-1.59%	118.01%	560.41%	-94.45%	257.37%	36.25%	-33.70%	54.47%
Invested Capital Q/Q Growth	1.30%	-2.02%	26.29%	0.03%	-0.95%	-2.00%	-1.86%	-0.73%	4.13%	1.12%	-10.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.01%	37.59%	37.60%	35.63%	35.86%	33.73%	34.49%	34.95%	35.38%	35.85%	35.12%
EBITDA Margin	20.14%	20.75%	23.24%	18.81%	16.22%	19.40%	19.35%	15.90%	20.04%	20.23%	16.74%
Operating Margin	12.95%	14.91%	16.22%	13.65%	11.56%	13.04%	13.52%	12.70%	15.19%	15.20%	14.91%
EBIT Margin	13.39%	14.25%	17.20%	13.18%	10.40%	13.56%	13.96%	10.90%	15.30%	14.59%	11.50%
Profit (Net Income) Margin	10.63%	10.68%	14.11%	11.30%	8.84%	12.29%	10.38%	8.88%	12.56%	10.50%	7.77%
Tax Burden Percent	82.91%	78.42%	83.23%	82.77%	81.41%	86.91%	74.56%	80.21%	80.78%	71.93%	68.20%
Interest Burden Percent	95.73%	95.52%	98.53%	103.54%	104.47%	104.23%	99.76%	101.61%	101.65%	100.07%	99.00%
Effective Tax Rate	17.09%	21.58%	16.77%	17.23%	18.59%	13.09%	25.44%	19.79%	19.22%	28.07%	31.80%
Return on Invested Capital (ROIC)	11.52%	12.59%	14.16%	13.32%	11.38%	14.45%	13.20%	12.88%	16.80%	15.94%	14.54%
ROIC Less NNEP Spread (ROIC-NNEP)	11.80%	15.20%	12.02%	13.31%	12.28%	13.04%	12.64%	17.50%	16.18%	16.69%	19.71%
Return on Net Nonoperating Assets (RNNOA)	-1.10%	-1.43%	-0.86%	-2.17%	-1.88%	-2.14%	-1.82%	-1.42%	-2.27%	-2.83%	-2.93%
Return on Equity (ROE)	10.43%	11.16%	13.30%	11.15%	9.50%	12.30%	11.38%	11.46%	14.53%	13.11%	11.61%
Cash Return on Invested Capital (CROIC)	-9.83%	-7.92%	-8.35%	17.23%	17.98%	14.59%	11.70%	20.46%	4.53%	1.93%	3.80%
Operating Return on Assets (OROA)	9.22%	9.75%	11.44%	9.17%	7.45%	10.02%	10.65%	8.59%	12.51%	12.12%	9.57%
Return on Assets (ROA)	7.32%	7.31%	9.38%	7.86%	6.34%	9.08%	7.92%	7.00%	10.27%	8.72%	6.46%
Return on Common Equity (ROCE)	10.43%	11.16%	13.30%	11.15%	9.50%	12.30%	11.38%	11.46%	14.53%	13.11%	11.61%
Return on Equity Simple (ROE_SIMPLE)	11.21%	0.00%	11.27%	10.54%	10.23%	0.00%	11.51%	11.12%	11.22%	0.00%	10.97%
Net Operating Profit after Tax (NOPAT)	14	15	18	15	12	14	14	15	18	16	15
NOPAT Margin	10.74%	11.70%	13.50%	11.30%	9.41%	11.33%	10.08%	10.18%	12.27%	10.93%	10.17%
Net Nonoperating Expense Percent (NNEP)	-0.27%	-2.61%	2.14%	0.00%	-0.90%	1.41%	0.56%	-4.63%	0.62%	-0.75%	-5.17%
Return On Investment Capital (ROIC_SIMPLE)	2.16%	2.40%	-	-	-	2.38%	-	-	-	2.64%	-
Cost of Revenue to Revenue	62.99%	62.41%	62.40%	64.37%	64.14%	66.27%	65.51%	65.05%	64.62%	64.15%	64.88%
SG&A Expenses to Revenue	18.78%	17.41%	17.00%	16.39%	17.70%	15.62%	13.87%	16.32%	15.05%	16.51%	15.80%
R&D to Revenue	4.92%	4.45%	3.80%	4.68%	5.25%	4.24%	4.70%	4.63%	4.51%	3.80%	4.09%
Operating Expenses to Revenue	24.06%	22.67%	21.38%	21.98%	24.30%	20.70%	20.97%	22.25%	20.19%	20.65%	20.21%
Earnings before Interest and Taxes (EBIT)	17	18	23	17	13	17	19	16	22	21	17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	25	26	31	24	20	24	26	23	29	29	25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.32	2.99	2.77	2.96	2.79	2.58	2.50	2.57	3.03	2.47	2.69
Price to Tangible Book Value (P/TBV)	7.22	9.50	9.47	5.74	5.50	5.12	4.93	5.22	6.27	5.08	5.37
Price to Revenue (P/Rev)	2.42	3.08	2.86	3.00	2.75	2.47	2.30	2.29	2.66	2.13	2.28
Price to Earnings (P/E)	20.68	27.33	24.55	28.08	27.33	22.44	21.68	23.11	27.03	20.95	24.51
Dividend Yield	0.39%	0.30%	0.33%	0.32%	0.34%	0.37%	0.38%	0.38%	0.33%	0.41%	0.39%
Earnings Yield	4.84%	3.66%	4.07%	3.56%	3.66%	4.46%	4.61%	4.33%	3.70%	4.77%	4.08%
Enterprise Value to Invested Capital (EV/IC)	2.33	3.00	2.74	3.40	3.19	2.93	2.78	2.83	3.32	2.71	2.93
Enterprise Value to Revenue (EV/Rev)	2.41	3.07	2.88	2.82	2.57	2.29	2.15	2.16	2.56	2.00	2.18
Enterprise Value to EBITDA (EV/EBITDA)	11.63	15.52	14.79	15.26	14.53	12.30	11.39	11.88	13.88	10.55	12.03
Enterprise Value to EBIT (EV/EBIT)	16.61	22.27	21.12	22.02	21.08	17.09	15.71	16.57	19.22	14.40	16.53
Enterprise Value to NOPAT (EV/NOPAT)	20.39	26.69	25.20	26.75	25.05	20.88	19.76	19.77	22.61	17.12	19.43
Enterprise Value to Operating Cash Flow (EV/OCF)	12.90	15.96	14.01	15.75	14.19	14.21	14.85	10.51	13.23	9.69	10.32
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	19.27	17.27	20.04	24.06	13.37	77.23	151.43	81.93
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.17	0.19	0.12	0.13	0.13	0.15	0.15	0.16	0.17	0.17
Long-Term Debt to Equity	0.16	0.17	0.19	0.12	0.13	0.13	0.15	0.15	0.16	0.17	0.17
Financial Leverage	-0.09	-0.09	-0.07	-0.16	-0.15	-0.16	-0.14	-0.08	-0.14	-0.17	-0.15
Leverage Ratio	1.41	1.43	1.47	1.42	1.43	1.44	1.47	1.47	1.44	1.46	1.46
Compound Leverage Factor	1.35	1.36	1.44	1.47	1.49	1.50	1.47	1.50	1.46	1.46	1.45
Debt to Total Capital	13.87%	14.67%	16.21%	11.06%	11.46%	11.36%	12.79%	12.87%	13.50%	14.18%	14.84%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	13.87%	14.67%	16.21%	11.06%	11.46%	11.36%	12.79%	12.87%	13.50%	14.18%	14.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.13%	85.33%	83.79%	88.94%	88.54%	88.64%	87.21%	87.13%	86.50%	85.82%	85.16%
Debt to EBITDA	0.81	0.89	1.03	0.68	0.72	0.66	0.72	0.72	0.74	0.75	0.82
Net Debt to EBITDA	-0.03	-0.03	0.08	-1.01	-1.01	-0.94	-0.78	-0.69	-0.59	-0.66	-0.60
Long-Term Debt to EBITDA	0.81	0.89	1.03	0.68	0.72	0.66	0.72	0.72	0.74	0.75	0.82
Debt to NOPAT	1.42	1.54	1.75	1.20	1.24	1.12	1.24	1.20	1.21	1.22	1.32
Net Debt to NOPAT	-0.06	-0.05	0.13	-1.77	-1.75	-1.59	-1.35	-1.15	-0.96	-1.07	-0.97
Long-Term Debt to NOPAT	1.42	1.54	1.75	1.20	1.24	1.12	1.24	1.20	1.21	1.22	1.32
Altman Z-Score	5.49	6.23	5.53	6.94	6.45	6.12	5.68	5.69	6.30	5.33	5.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.63	2.50	2.46	3.41	3.32	3.29	3.23	3.08	3.05	2.89	2.68
Quick Ratio	1.86	1.76	1.75	2.67	2.53	2.50	2.41	2.32	2.28	2.20	2.01
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-95	-82	-82	36	36	17	2.52	45	-29	-45	-34
Operating Cash Flow to CapEx	347.55%	425.41%	914.36%	423.31%	453.80%	915.73%	805.20%	593.39%	246.39%	501.83%	2,661.39%
Free Cash Flow to Firm to Interest Expense	-81.22	-63.64	-62.38	42.92	45.36	20.28	2.53	55.58	-41.62	-64.55	-99.10
Operating Cash Flow to Interest Expense	13.30	20.04	27.08	23.56	22.86	39.01	22.20	28.63	16.12	36.27	176.57
Operating Cash Flow Less CapEx to Interest Expense	9.47	15.33	24.12	18.00	17.82	34.75	19.44	23.81	9.58	29.04	169.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.68	0.66	0.70	0.72	0.74	0.76	0.79	0.82	0.83	0.83
Accounts Receivable Turnover	6.36	6.60	5.83	5.63	5.94	6.49	6.09	5.96	6.07	6.78	6.59
Inventory Turnover	5.82	5.75	5.38	5.87	5.71	5.88	5.72	5.98	6.51	6.73	6.45
Fixed Asset Turnover	5.56	5.52	5.51	5.52	5.64	5.80	6.02	6.02	6.05	6.04	6.13
Accounts Payable Turnover	7.32	7.58	6.96	7.13	6.99	7.44	6.37	6.66	6.65	6.92	6.43
Days Sales Outstanding (DSO)	57.36	55.28	62.58	64.79	61.40	56.20	59.94	61.25	60.13	53.84	55.41
Days Inventory Outstanding (DIO)	62.67	63.48	67.90	62.18	63.98	62.07	63.86	61.08	56.07	54.20	56.56
Days Payable Outstanding (DPO)	49.83	48.12	52.47	51.16	52.25	49.09	57.26	54.84	54.86	52.74	56.72
Cash Conversion Cycle (CCC)	70.19	70.63	78.00	75.81	73.13	69.19	66.54	67.49	61.35	55.30	55.24
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	535	528	539	427	426	430	439	448	451	433	428
Invested Capital Turnover	1.07	1.08	1.05	1.18	1.21	1.28	1.31	1.26	1.37	1.46	1.43
Increase / (Decrease) in Invested Capital	108	97	99	-21	-25	-2.54	11	-31	47	61	49
Enterprise Value (EV)	1,245	1,585	1,477	1,451	1,362	1,262	1,221	1,266	1,496	1,175	1,256
Market Capitalization	1,248	1,588	1,469	1,548	1,457	1,358	1,304	1,340	1,559	1,248	1,319
Book Value per Share	$17.92	$17.63	$17.48	$17.10	$16.96	$16.91	$16.67	$16.53	$16.24	$15.88	$15.40
Tangible Book Value per Share	$5.76	$5.55	$5.11	$8.83	$8.62	$8.51	$8.44	$8.14	$7.86	$7.71	$7.70
Total Capital	625	622	634	588	589	594	599	598	594	590	576
Total Debt	87	91	103	65	68	68	77	77	80	84	85
Total Long-Term Debt	87	91	103	65	68	68	77	77	80	84	85
Net Debt	-3.59	-3.08	7.83	-96	-95	-96	-83	-74	-63	-73	-62
Capital Expenditures (CapEx)	4.47	6.10	3.87	4.64	4.04	3.50	2.75	3.95	4.54	5.07	2.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	61	52	57	61	60	58	71	72	73	56	57
Debt-free Net Working Capital (DFNWC)	151	147	152	222	222	222	231	223	217	213	204
Net Working Capital (NWC)	151	147	152	222	222	222	231	223	217	213	204
Net Nonoperating Expense (NNE)	0.14	1.30	-0.81	-0.00	0.71	-1.19	-0.41	1.89	-0.43	0.62	3.65
Net Nonoperating Obligations (NNO)	-3.59	-3.08	7.83	-96	-95	-96	-83	-74	-63	-73	-62
Total Depreciation and Amortization (D&A)	8.49	8.28	7.99	7.33	7.33	7.29	7.25	7.26	6.92	8.03	7.96
Debt-free, Cash-free Net Working Capital to Revenue	11.79%	10.16%	11.09%	11.87%	11.29%	10.62%	12.46%	12.27%	12.53%	9.60%	9.80%
Debt-free Net Working Capital to Revenue	29.30%	28.45%	29.58%	43.17%	41.92%	40.39%	40.65%	38.04%	37.06%	36.33%	35.43%
Net Working Capital to Revenue	29.30%	28.45%	29.58%	43.17%	41.92%	40.39%	40.65%	38.04%	37.06%	36.33%	35.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.45	$0.45	$0.62	$0.48	$0.36	$0.49	$0.45	$0.41	$0.58	$0.47	$0.37
Adjusted Weighted Average Basic Shares Outstanding	30.01M	30.41M	30.30M	30.51M	30.74M	31.36M	31.30M	31.49M	31.63M	31.97M	31.87M
Adjusted Diluted Earnings per Share	$0.44	$0.44	$0.61	$0.48	$0.36	$0.49	$0.44	$0.41	$0.58	$0.46	$0.37
Adjusted Weighted Average Diluted Shares Outstanding	30.33M	30.72M	30.54M	30.73M	30.99M	31.58M	31.51M	31.69M	31.89M	32.24M	32.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	29.84M	30.04M	30.12M	30.37M	30.57M	30.79M	31.16M	31.36M	31.54M	31.67M	31.88M
Normalized Net Operating Profit after Tax (NOPAT)	14	16	19	16	13	15	16	16	19	16	16
Normalized NOPAT Margin	11.03%	12.34%	13.98%	12.05%	10.51%	12.06%	11.87%	11.23%	12.77%	11.18%	10.39%
Pre Tax Income Margin	12.82%	13.61%	16.95%	13.65%	10.86%	14.14%	13.93%	11.08%	15.55%	14.60%	11.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.43	14.02	17.43	20.60	16.32	20.57	18.84	19.35	32.19	29.57	51.09
NOPAT to Interest Expense	11.57	11.51	13.68	17.65	14.77	17.19	13.60	18.07	25.81	22.16	45.16
EBIT Less CapEx to Interest Expense	10.61	9.31	14.47	15.03	11.28	16.31	16.08	14.52	25.65	22.34	44.46
NOPAT Less CapEx to Interest Expense	7.74	6.80	10.71	12.08	9.74	12.93	10.85	13.25	19.27	14.94	38.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	8.04%	8.41%	8.23%	9.01%	9.38%	8.33%	8.43%	8.78%	8.87%	8.61%	9.57%
Augmented Payout Ratio	69.51%	81.70%	91.51%	92.93%	92.08%	75.94%	64.77%	55.94%	54.51%	44.61%	41.71%

Frequently Asked Questions About CTS's Financials

When does CTS's financial year end?

According to the most recent income statement we have on file, CTS's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CTS's net income changed over the last 10 years?

CTS's net income appears to be on an upward trend, with a most recent value of $58.11 million in 2024, rising from $26.52 million in 2014. The previous period was $60.53 million in 2023. Check out CTS's forecast to explore projected trends and price targets.

What is CTS's operating income?

CTS's total operating income in 2024 was $72.78 million, based on the following breakdown:

Total Gross Profit: $189.15 million
Total Operating Expenses: $116.37 million

How has CTS revenue changed over the last 10 years?

Over the last 10 years, CTS's total revenue changed from $404.02 million in 2014 to $515.77 million in 2024, a change of 27.7%.

How much debt does CTS have?

CTS's total liabilities were at $235.26 million at the end of 2024, a 9.8% increase from 2023, and a 40.8% increase since 2014.

How much cash does CTS have?

In the past 10 years, CTS's cash and equivalents has ranged from $91.77 million in 2020 to $163.88 million in 2023, and is currently $94.33 million as of their latest financial filing in 2024.

How has CTS's book value per share changed over the last 10 years?

Over the last 10 years, CTS's book value per share changed from 8.66 in 2014 to 17.63 in 2024, a change of 103.6%.

Related Companies

This page (NYSE:CTS) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CTS (CTS) Financials

Frequently Asked Questions About CTS's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CTS (CTS) Financials

Annual Income Statements for CTS

Quarterly Income Statements for CTS

Annual Cash Flow Statements for CTS

Quarterly Cash Flow Statements for CTS

Annual Balance Sheets for CTS

Quarterly Balance Sheets for CTS

Annual Metrics And Ratios for CTS

Quarterly Metrics And Ratios for CTS

Frequently Asked Questions About CTS's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools